Target intelligence / Profile preview

Polycystin 1, transient receptor potential channel interacting pseudogene 2 (PKD1P2)

Target
PKD1P2
Molecular classification
Pseudogene (not a protein-coding gene)
01

Overview

PKD1P2 is a human pseudogene that resembles the functional PKD1 gene, which encodes polycystin 1—a protein involved in the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD)[1][4][8][10]. PKD1P2 does not encode a functional protein; instead, it is one of several pseudogenes that arose from gene duplication events and retains substantial sequence similarity to PKD1. Although PKD1P2 itself has no known biological activity or disease association, its presence can complicate genetic diagnosis of ADPKD because standard sequencing approaches may inadvertently amplify or detect variants from PKD1P2 rather than PKD1, potentially leading to misdiagnosis[10]. Thus, PKD1P2 is relevant primarily in the context of genetic testing, but not as a receptor, enzyme, or other therapeutic target[3][9][10][11].

Other names
HG2polycystic kidney disease 1 (autosomal dominant) pseudogene 2PKD1P2
02

Biological functions

No direct biological function; PKD1P2 is a non-functional copy related to the PKD1 gene
03

Disease associations

No direct role; can cause interference in genetic testing for polycystic kidney disease due to high sequence homology with PKD1. It does not cause disease itself.
04

Safety considerations

None are attributed to PKD1P2 itself, but its high sequence similarity to PKD1 can complicate molecular genetic testing for polycystic kidney disease due to potential misamplification or erroneous variant assignment[10].

Beyond the preview

Go deeper on Polycystin 1, transient receptor potential channel interacting pseudogene 2 (PKD1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polycystin 1, transient receptor potential channel interacting pseudogene 2 (PKD1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call